Verastem, Inc. (VSTM)

↓ Download CSV

CIK 0001526119 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated MA
  • Fiscal year ends Dec 31

In fiscal 2025, Verastem, Inc. reported revenue of $30.91M, up 209.1% from the prior year. The company ran a net loss, with a net margin of -677.6%. It held $246.44M in total assets against $189.25M in total liabilities.

Key ratios (FY2025)

-550.3%
Operating margin
-677.6%
Net margin
-366.2%
Return on equity
+209.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$30.91M$10.00M$2.60M$2.05M
Cost of Revenue$165.0K
Operating Income-$170.13M-$114.96M-$92.08M-$72.94M-$61.41M-$49.36M-$132.34M-$94.78M-$67.80M-$37.00M
Net Income-$209.47M-$130.64M-$87.37M-$73.81M-$71.20M-$67.73M-$149.21M-$72.43M-$67.80M-$36.44M
EPS (Diluted)$-3.02$-3.66$-3.96$-4.57$-4.90$-0.44$-2.00$-1.37$-1.76$-0.99
Total Assets$246.44M$101.54M$149.72M$95.05M$108.66M$154.35M$145.05M$277.24M$89.79M$83.63M
Total Liabilities$189.25M$130.43M$71.19M$47.66M$21.10M$39.08M$137.87M$152.94M$32.11M$11.33M
Shareholders' Equity$57.20M-$28.89M$57.37M$47.39M$87.56M$115.27M$7.17M$124.30M$57.68M$72.30M
Cash & Equivalents$204.99M$88.82M$77.91M$74.93M$21.25M$67.78M$43.51M$129.87M$82.18M$32.35M
Operating Cash Flow-$137.51M-$104.77M-$86.46M-$63.67M-$53.50M-$33.51M-$138.52M-$74.52M-$57.31M-$29.48M
Capital Expenditures$28.0K$196.0K$33.0K$7.0K$1.51M$39.0K
Shares Outstanding77.74M44.78M25.28M16.71M185.29M170.46M80.12M73.81M50.80M36.99M